BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24970806)

  • 1. miR-942 decreases TRAIL-induced apoptosis through ISG12a downregulation and is regulated by AKT.
    Liu N; Zuo C; Wang X; Chen T; Yang D; Wang J; Zhu H
    Oncotarget; 2014 Jul; 5(13):4959-71. PubMed ID: 24970806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ISG12a and its interaction partner NR4A1 are involved in TRAIL-induced apoptosis in hepatoma cells.
    Liu N; Wu Z; Chen A; Chai D; Li L; Zhang L; Zheng J
    J Cell Mol Med; 2019 May; 23(5):3520-3529. PubMed ID: 30821058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MiR-942 mediates hepatitis C virus-induced apoptosis via regulation of ISG12a.
    Yang D; Meng X; Xue B; Liu N; Wang X; Zhu H
    PLoS One; 2014; 9(4):e94501. PubMed ID: 24727952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-138 enhances TRAIL-induced apoptosis through interferon-stimulated gene 15 downregulation in hepatocellular carcinoma cells.
    Zuo C; Sheng X; Liu Z; Ma M; Xiong S; Deng H; Li S; Yang D; Wang X; Xiao H; Quan H; Xia M
    Tumour Biol; 2017 Jun; 39(6):1010428317710410. PubMed ID: 28639887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of AAV-TRAIL with miR-221-Zip Therapeutic Strategy Overcomes the Resistance to TRAIL Induced Apoptosis in Liver Cancer.
    Ma S; Sun J; Guo Y; Zhang P; Liu Y; Zheng D; Shi J
    Theranostics; 2017; 7(13):3228-3242. PubMed ID: 28900506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non-small-cell lung cancer through BIM down-regulation.
    Romano G; Acunzo M; Garofalo M; Di Leva G; Cascione L; Zanca C; Bolon B; Condorelli G; Croce CM
    Proc Natl Acad Sci U S A; 2012 Oct; 109(41):16570-5. PubMed ID: 23012423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin.
    Xu S; Li D; Li T; Qiao L; Li K; Guo L; Liu Y
    Cell Physiol Biochem; 2018; 51(5):2212-2223. PubMed ID: 30537730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of miR-25 increases the sensitivity of liver cancer stem cells to TRAIL-induced apoptosis via PTEN/PI3K/Akt/Bad signaling pathway.
    Feng X; Jiang J; Shi S; Xie H; Zhou L; Zheng S
    Int J Oncol; 2016 Dec; 49(6):2600-2610. PubMed ID: 27840896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Down-modulation of expression, or dephosphorylation, of IG20/MADD in tumor necrosis factor-related apoptosis-inducing ligand-resistant thyroid cancer cells makes them susceptible to treatment with this ligand.
    Li LC; Jayarama S; Pilli T; Qian L; Pacini F; Prabhakar BS
    Thyroid; 2013 Jan; 23(1):70-8. PubMed ID: 22998497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells.
    Quintavalle C; Donnarumma E; Iaboni M; Roscigno G; Garofalo M; Romano G; Fiore D; De Marinis P; Croce CM; Condorelli G
    Oncogene; 2013 Aug; 32(34):4001-8. PubMed ID: 22964638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The inhibition of Bid expression by Akt leads to resistance to TRAIL-induced apoptosis in ovarian cancer cells.
    Goncharenko-Khaider N; Lane D; Matte I; Rancourt C; Piché A
    Oncogene; 2010 Oct; 29(40):5523-36. PubMed ID: 20661217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222.
    Acunzo M; Visone R; Romano G; Veronese A; Lovat F; Palmieri D; Bottoni A; Garofalo M; Gasparini P; Condorelli G; Chiariello M; Croce CM
    Oncogene; 2012 Feb; 31(5):634-42. PubMed ID: 21706050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. microRNA-7 upregulates death receptor 5 and primes resistant brain tumors to caspase-mediated apoptosis.
    Bhere D; Tamura K; Wakimoto H; Choi SH; Purow B; Debatisse J; Shah K
    Neuro Oncol; 2018 Jan; 20(2):215-224. PubMed ID: 29016934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The herbal compound cryptotanshinone restores sensitivity in cancer cells that are resistant to the tumor necrosis factor-related apoptosis-inducing ligand.
    Tse AK; Chow KY; Cao HH; Cheng CY; Kwan HY; Yu H; Zhu GY; Wu YC; Fong WF; Yu ZL
    J Biol Chem; 2013 Oct; 288(41):29923-33. PubMed ID: 23986445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncogene metadherin modulates the apoptotic pathway based on the tumor necrosis factor superfamily member TRAIL (Tumor Necrosis Factor-related Apoptosis-inducing Ligand) in breast cancer.
    Zhang N; Wang X; Huo Q; Li X; Wang H; Schneider P; Hu G; Yang Q
    J Biol Chem; 2013 Mar; 288(13):9396-407. PubMed ID: 23408429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Programmed cell death 4 (PDCD4) enhances the sensitivity of gastric cancer cells to TRAIL-induced apoptosis by inhibiting the PI3K/Akt signaling pathway.
    Wang WQ; Zhang H; Wang HB; Sun YG; Peng ZH; Zhou G; Yang SM; Wang RQ; Fang DC
    Mol Diagn Ther; 2010 Jun; 14(3):155-61. PubMed ID: 20560677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dovitinib sensitizes hepatocellular carcinoma cells to TRAIL and tigatuzumab, a novel anti-DR5 antibody, through SHP-1-dependent inhibition of STAT3.
    Chen KF; Chen HL; Liu CY; Tai WT; Ichikawa K; Chen PJ; Cheng AL
    Biochem Pharmacol; 2012 Mar; 83(6):769-77. PubMed ID: 22230479
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rocaglamide overcomes tumor necrosis factor-related apoptosis-inducing ligand resistance in hepatocellular carcinoma cells by attenuating the inhibition of caspase-8 through cellular FLICE-like-inhibitory protein downregulation.
    Luan Z; He Y; He F; Chen Z
    Mol Med Rep; 2015 Jan; 11(1):203-11. PubMed ID: 25333816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of microRNA-30a-5p inhibits liver cancer cell proliferation and induces apoptosis by targeting MTDH/PTEN/AKT pathway.
    Li WF; Dai H; Ou Q; Zuo GQ; Liu CA
    Tumour Biol; 2016 May; 37(5):5885-95. PubMed ID: 26589417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding of tolerance in TRAIL-induced apoptosis and cancelation of its machinery by α-mangostin, a xanthone derivative.
    Kumazaki M; Shinohara H; Taniguchi K; Ueda H; Nishi M; Ryo A; Akao Y
    Oncotarget; 2015 Sep; 6(28):25828-42. PubMed ID: 26304927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.